FiercePharma

U.S. FDA Approves BOTOX® (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults

- BOTOX® is the First and Only FDA-Approved Neurotoxin Treatment for Both Upper and Lower Limb Spasticity - DUBLIN, Jan. 22, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global ...
FiercePharma

U.S. FDA Approves BOTOX® (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults

DUBLIN, Jan. 22, 2016 /PRNewswire/ -- Allergan plc (AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has approved BOTOX® ...